MMP9 and cancer: In fact, the inhibition of NLRP3 expression reduced the migratory and invasive capacities of cancer cells, whilst also inverting the mesenchymal condition by reducing vimentin and Matrix metalloproteinase-9 (MMP9) expression and increasing E-cadherin expression [33,93].